ACADIA PHARMACEUTICALS INC (ACAD) › Operating Cash FlowACADIA PHARMACEUTICALS INC (ACAD) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$13.73M2010: -$10.70M2011: -$19.90M2012: -$21.63M2016: -$208.41M2017: -$217.76M2018: -$167.47M2019: -$151.13M2020: -$136.17M2021: -$125.66M2022: -$114.03M2023: $16.70M2024: $157.72M2025: $109.84M$109.84M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$109.84M-30.4%2024$157.72M+844.3%2023$16.70M+114.6%2022-$114.03M+9.3%2021-$125.66M+7.7%2020-$136.17M+9.9%2019-$151.13M+9.8%2018-$167.47M+23.1%2017-$217.76M-4.5%2016-$208.41M—2012-$21.63M-8.7%2011-$19.90M-85.9%2010-$10.70M+22.0%2009-$13.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share